FDA approves UroGen’s Zusduri to treat recurrent bladder cancer
17th June 2025 Uncategorised 0
Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US

More: FDA approves UroGen’s Zusduri to treat recurrent bladder cancer
Source: News
